What is the current valuation of the behavioral health market in 2025?

The behavioral health market is valued at approximately 183.2 USD Billion in 2024. Read More

What is the projected market size for the behavioral health sector by 2035?

The market is expected to reach a valuation of 293.5 USD Billion by 2035. Read More

What is the expected compound annual growth rate (CAGR) for the behavioral health market from 2025 to 2035?

The expected CAGR for the behavioral health market during the forecast period 2025 - 2035 is 4.38%. Read More

Which treatment type segment is projected to have the highest valuation in 2035?

By 2035, the medication segment is projected to reach approximately 70.0 USD Billion. Read More

What are the projected values for anxiety disorders in the behavioral health market by 2035?

Anxiety disorders are expected to reach a valuation of around 58.0 USD Billion by 2035. Read More

How does demographic segmentation impact the behavioral health market?

By 2035, the occupation demographic segment is projected to reach approximately 78.5 USD Billion. Read More

What is the expected growth in outpatient services within the behavioral health market by 2035?

Outpatient services are projected to grow to around 80.0 USD Billion by 2035. Read More

Which key players are leading the behavioral health market in 2025?

Key players in the market include UnitedHealth Group, Anthem, Cigna, and Magellan Health. Read More

What is the projected value of telehealth services in the behavioral health market by 2035?

Telehealth services are expected to reach a valuation of approximately 68.5 USD Billion by 2035. Read More

What is the anticipated value of psychiatrists in the behavioral health market by 2035?

The psychiatrists segment is projected to reach around 56.0 USD Billion by 2035. Read More

behavioral-health-market

ID: MRFR/HC/64229-HCR

200 Pages

Nidhi Mandole

Last Updated: March 28, 2026

Behavioral Health Market Research Report: Size, Share, Trend Analysis By Disorder Type (Anxiety Disorders, Mood Disorders, Personality Disorders, Psychotic Disorders, Substance Use Disorders), By Provider Type (Psychiatrists, Psychologists, Licensed Clinical Social Workers, Counselors, Nurse Practitioners), By Treatment Type (Psychotherapy, Medication, Counseling, Support Groups, Teletherapy), By Service Delivery Model (Inpatient Services, Outpatient Services, Residential Treatment, Community-Based Services, Telehealth Services), By Demographic Segmentation (Age, Gender, Income Level, Education Level, Occupation) – Growth Outlook & Industry Forecast To 2035

behavioral-health-market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)4.38%

2024 Market Size$ 183.2 Billion

2025 Market Size$ 191.22 Billion

2035 Market Size$ 293.5 Billion

Key Players

UnitedHealth Group

Anthem

Cigna

Magellan Health

Centene Corporation

Kaiser Permanente

Trends

Integration of Technology in Treatment
Focus on Preventive Care
Holistic Approaches to Mental Health

Opportunities

Emphasis on Integrated Care Models
Growing Acceptance of Telehealth Services
Rising Prevalence of Mental Health Disorders

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Treatment Type (USD Billion)
  1. 4.1.1 Psychotherapy
  2. 4.1.2 Medication
  3. 4.1.3 Counseling
  4. 4.1.4 Support Groups
  5. 4.1.5 Teletherapy
2. 4.2 Healthcare, BY Disorder Type (USD Billion)
  1. 4.2.1 Anxiety Disorders
  2. 4.2.2 Mood Disorders
  3. 4.2.3 Personality Disorders
  4. 4.2.4 Psychotic Disorders
  5. 4.2.5 Substance Use Disorders
3. 4.3 Healthcare, BY Demographic Segmentation (USD Billion)
  1. 4.3.1 Age
  2. 4.3.2 Gender
  3. 4.3.3 Income Level
  4. 4.3.4 Education Level
  5. 4.3.5 Occupation
4. 4.4 Healthcare, BY Service Delivery Model (USD Billion)
  1. 4.4.1 Inpatient Services
  2. 4.4.2 Outpatient Services
  3. 4.4.3 Residential Treatment
  4. 4.4.4 Community-Based Services
  5. 4.4.5 Telehealth Services
5. 4.5 Healthcare, BY Provider Type (USD Billion)
  1. 4.5.1 Psychiatrists
  2. 4.5.2 Psychologists
  3. 4.5.3 Licensed Clinical Social Workers
  4. 4.5.4 Counselors
  5. 4.5.5 Nurse Practitioners
6. 4.6 Healthcare, BY Region (USD Billion)
  1. 4.6.1 North America
    1. 4.6.1.1 US
    2. 4.6.1.2 Canada
  2. 4.6.2 Europe
    1. 4.6.2.1 Germany
    2. 4.6.2.2 UK
    3. 4.6.2.3 France
    4. 4.6.2.4 Russia
    5. 4.6.2.5 Italy
    6. 4.6.2.6 Spain
    7. 4.6.2.7 Rest of Europe
  3. 4.6.3 APAC
    1. 4.6.3.1 China
    2. 4.6.3.2 India
    3. 4.6.3.3 Japan
    4. 4.6.3.4 South Korea
    5. 4.6.3.5 Malaysia
    6. 4.6.3.6 Thailand
    7. 4.6.3.7 Indonesia
    8. 4.6.3.8 Rest of APAC
  4. 4.6.4 South America
    1. 4.6.4.1 Brazil
    2. 4.6.4.2 Mexico
    3. 4.6.4.3 Argentina
    4. 4.6.4.4 Rest of South America
  5. 4.6.5 MEA
    1. 4.6.5.1 GCC Countries
    2. 4.6.5.2 South Africa
    3. 4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 UnitedHealth Group (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Anthem (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Cigna (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Magellan Health (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Centene Corporation (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Kaiser Permanente (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Humana (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Molina Healthcare (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Beacon Health Options (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY TREATMENT TYPE
4. 6.4 US MARKET ANALYSIS BY DISORDER TYPE
5. 6.5 US MARKET ANALYSIS BY DEMOGRAPHIC SEGMENTATION
6. 6.6 US MARKET ANALYSIS BY SERVICE DELIVERY MODEL
7. 6.7 US MARKET ANALYSIS BY PROVIDER TYPE
8. 6.8 CANADA MARKET ANALYSIS BY TREATMENT TYPE
9. 6.9 CANADA MARKET ANALYSIS BY DISORDER TYPE
10. 6.10 CANADA MARKET ANALYSIS BY DEMOGRAPHIC SEGMENTATION
11. 6.11 CANADA MARKET ANALYSIS BY SERVICE DELIVERY MODEL
12. 6.12 CANADA MARKET ANALYSIS BY PROVIDER TYPE
13. 6.13 EUROPE MARKET ANALYSIS
14. 6.14 GERMANY MARKET ANALYSIS BY TREATMENT TYPE
15. 6.15 GERMANY MARKET ANALYSIS BY DISORDER TYPE
16. 6.16 GERMANY MARKET ANALYSIS BY DEMOGRAPHIC SEGMENTATION
17. 6.17 GERMANY MARKET ANALYSIS BY SERVICE DELIVERY MODEL
18. 6.18 GERMANY MARKET ANALYSIS BY PROVIDER TYPE
19. 6.19 UK MARKET ANALYSIS BY TREATMENT TYPE
20. 6.20 UK MARKET ANALYSIS BY DISORDER TYPE
21. 6.21 UK MARKET ANALYSIS BY DEMOGRAPHIC SEGMENTATION
22. 6.22 UK MARKET ANALYSIS BY SERVICE DELIVERY MODEL
23. 6.23 UK MARKET ANALYSIS BY PROVIDER TYPE
24. 6.24 FRANCE MARKET ANALYSIS BY TREATMENT TYPE
25. 6.25 FRANCE MARKET ANALYSIS BY DISORDER TYPE
26. 6.26 FRANCE MARKET ANALYSIS BY DEMOGRAPHIC SEGMENTATION
27. 6.27 FRANCE MARKET ANALYSIS BY SERVICE DELIVERY MODEL
28. 6.28 FRANCE MARKET ANALYSIS BY PROVIDER TYPE
29. 6.29 RUSSIA MARKET ANALYSIS BY TREATMENT TYPE
30. 6.30 RUSSIA MARKET ANALYSIS BY DISORDER TYPE
31. 6.31 RUSSIA MARKET ANALYSIS BY DEMOGRAPHIC SEGMENTATION
32. 6.32 RUSSIA MARKET ANALYSIS BY SERVICE DELIVERY MODEL
33. 6.33 RUSSIA MARKET ANALYSIS BY PROVIDER TYPE
34. 6.34 ITALY MARKET ANALYSIS BY TREATMENT TYPE
35. 6.35 ITALY MARKET ANALYSIS BY DISORDER TYPE
36. 6.36 ITALY MARKET ANALYSIS BY DEMOGRAPHIC SEGMENTATION
37. 6.37 ITALY MARKET ANALYSIS BY SERVICE DELIVERY MODEL
38. 6.38 ITALY MARKET ANALYSIS BY PROVIDER TYPE
39. 6.39 SPAIN MARKET ANALYSIS BY TREATMENT TYPE
40. 6.40 SPAIN MARKET ANALYSIS BY DISORDER TYPE
41. 6.41 SPAIN MARKET ANALYSIS BY DEMOGRAPHIC SEGMENTATION
42. 6.42 SPAIN MARKET ANALYSIS BY SERVICE DELIVERY MODEL
43. 6.43 SPAIN MARKET ANALYSIS BY PROVIDER TYPE
44. 6.44 REST OF EUROPE MARKET ANALYSIS BY TREATMENT TYPE
45. 6.45 REST OF EUROPE MARKET ANALYSIS BY DISORDER TYPE
46. 6.46 REST OF EUROPE MARKET ANALYSIS BY DEMOGRAPHIC SEGMENTATION
47. 6.47 REST OF EUROPE MARKET ANALYSIS BY SERVICE DELIVERY MODEL
48. 6.48 REST OF EUROPE MARKET ANALYSIS BY PROVIDER TYPE
49. 6.49 APAC MARKET ANALYSIS
50. 6.50 CHINA MARKET ANALYSIS BY TREATMENT TYPE
51. 6.51 CHINA MARKET ANALYSIS BY DISORDER TYPE
52. 6.52 CHINA MARKET ANALYSIS BY DEMOGRAPHIC SEGMENTATION
53. 6.53 CHINA MARKET ANALYSIS BY SERVICE DELIVERY MODEL
54. 6.54 CHINA MARKET ANALYSIS BY PROVIDER TYPE
55. 6.55 INDIA MARKET ANALYSIS BY TREATMENT TYPE
56. 6.56 INDIA MARKET ANALYSIS BY DISORDER TYPE
57. 6.57 INDIA MARKET ANALYSIS BY DEMOGRAPHIC SEGMENTATION
58. 6.58 INDIA MARKET ANALYSIS BY SERVICE DELIVERY MODEL
59. 6.59 INDIA MARKET ANALYSIS BY PROVIDER TYPE
60. 6.60 JAPAN MARKET ANALYSIS BY TREATMENT TYPE
61. 6.61 JAPAN MARKET ANALYSIS BY DISORDER TYPE
62. 6.62 JAPAN MARKET ANALYSIS BY DEMOGRAPHIC SEGMENTATION
63. 6.63 JAPAN MARKET ANALYSIS BY SERVICE DELIVERY MODEL
64. 6.64 JAPAN MARKET ANALYSIS BY PROVIDER TYPE
65. 6.65 SOUTH KOREA MARKET ANALYSIS BY TREATMENT TYPE
66. 6.66 SOUTH KOREA MARKET ANALYSIS BY DISORDER TYPE
67. 6.67 SOUTH KOREA MARKET ANALYSIS BY DEMOGRAPHIC SEGMENTATION
68. 6.68 SOUTH KOREA MARKET ANALYSIS BY SERVICE DELIVERY MODEL
69. 6.69 SOUTH KOREA MARKET ANALYSIS BY PROVIDER TYPE
70. 6.70 MALAYSIA MARKET ANALYSIS BY TREATMENT TYPE
71. 6.71 MALAYSIA MARKET ANALYSIS BY DISORDER TYPE
72. 6.72 MALAYSIA MARKET ANALYSIS BY DEMOGRAPHIC SEGMENTATION
73. 6.73 MALAYSIA MARKET ANALYSIS BY SERVICE DELIVERY MODEL
74. 6.74 MALAYSIA MARKET ANALYSIS BY PROVIDER TYPE
75. 6.75 THAILAND MARKET ANALYSIS BY TREATMENT TYPE
76. 6.76 THAILAND MARKET ANALYSIS BY DISORDER TYPE
77. 6.77 THAILAND MARKET ANALYSIS BY DEMOGRAPHIC SEGMENTATION
78. 6.78 THAILAND MARKET ANALYSIS BY SERVICE DELIVERY MODEL
79. 6.79 THAILAND MARKET ANALYSIS BY PROVIDER TYPE
80. 6.80 INDONESIA MARKET ANALYSIS BY TREATMENT TYPE
81. 6.81 INDONESIA MARKET ANALYSIS BY DISORDER TYPE
82. 6.82 INDONESIA MARKET ANALYSIS BY DEMOGRAPHIC SEGMENTATION
83. 6.83 INDONESIA MARKET ANALYSIS BY SERVICE DELIVERY MODEL
84. 6.84 INDONESIA MARKET ANALYSIS BY PROVIDER TYPE
85. 6.85 REST OF APAC MARKET ANALYSIS BY TREATMENT TYPE
86. 6.86 REST OF APAC MARKET ANALYSIS BY DISORDER TYPE
87. 6.87 REST OF APAC MARKET ANALYSIS BY DEMOGRAPHIC SEGMENTATION
88. 6.88 REST OF APAC MARKET ANALYSIS BY SERVICE DELIVERY MODEL
89. 6.89 REST OF APAC MARKET ANALYSIS BY PROVIDER TYPE
90. 6.90 SOUTH AMERICA MARKET ANALYSIS
91. 6.91 BRAZIL MARKET ANALYSIS BY TREATMENT TYPE
92. 6.92 BRAZIL MARKET ANALYSIS BY DISORDER TYPE
93. 6.93 BRAZIL MARKET ANALYSIS BY DEMOGRAPHIC SEGMENTATION
94. 6.94 BRAZIL MARKET ANALYSIS BY SERVICE DELIVERY MODEL
95. 6.95 BRAZIL MARKET ANALYSIS BY PROVIDER TYPE
96. 6.96 MEXICO MARKET ANALYSIS BY TREATMENT TYPE
97. 6.97 MEXICO MARKET ANALYSIS BY DISORDER TYPE
98. 6.98 MEXICO MARKET ANALYSIS BY DEMOGRAPHIC SEGMENTATION
99. 6.99 MEXICO MARKET ANALYSIS BY SERVICE DELIVERY MODEL
100. 6.100 MEXICO MARKET ANALYSIS BY PROVIDER TYPE
101. 6.101 ARGENTINA MARKET ANALYSIS BY TREATMENT TYPE
102. 6.102 ARGENTINA MARKET ANALYSIS BY DISORDER TYPE
103. 6.103 ARGENTINA MARKET ANALYSIS BY DEMOGRAPHIC SEGMENTATION
104. 6.104 ARGENTINA MARKET ANALYSIS BY SERVICE DELIVERY MODEL
105. 6.105 ARGENTINA MARKET ANALYSIS BY PROVIDER TYPE
106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY TREATMENT TYPE
107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY DISORDER TYPE
108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY DEMOGRAPHIC SEGMENTATION
109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY SERVICE DELIVERY MODEL
110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY PROVIDER TYPE
111. 6.111 MEA MARKET ANALYSIS
112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY TREATMENT TYPE
113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY DISORDER TYPE
114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY DEMOGRAPHIC SEGMENTATION
115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY SERVICE DELIVERY MODEL
116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY PROVIDER TYPE
117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY TREATMENT TYPE
118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY DISORDER TYPE
119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY DEMOGRAPHIC SEGMENTATION
120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY SERVICE DELIVERY MODEL
121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY PROVIDER TYPE
122. 6.122 REST OF MEA MARKET ANALYSIS BY TREATMENT TYPE
123. 6.123 REST OF MEA MARKET ANALYSIS BY DISORDER TYPE
124. 6.124 REST OF MEA MARKET ANALYSIS BY DEMOGRAPHIC SEGMENTATION
125. 6.125 REST OF MEA MARKET ANALYSIS BY SERVICE DELIVERY MODEL
126. 6.126 REST OF MEA MARKET ANALYSIS BY PROVIDER TYPE
127. 6.127 KEY BUYING CRITERIA OF HEALTHCARE
128. 6.128 RESEARCH PROCESS OF MRFR
129. 6.129 DRO ANALYSIS OF HEALTHCARE
130. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
131. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
132. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
133. 6.133 HEALTHCARE, BY TREATMENT TYPE, 2024 (% SHARE)
134. 6.134 HEALTHCARE, BY TREATMENT TYPE, 2024 TO 2035 (USD Billion)
135. 6.135 HEALTHCARE, BY DISORDER TYPE, 2024 (% SHARE)
136. 6.136 HEALTHCARE, BY DISORDER TYPE, 2024 TO 2035 (USD Billion)
137. 6.137 HEALTHCARE, BY DEMOGRAPHIC SEGMENTATION, 2024 (% SHARE)
138. 6.138 HEALTHCARE, BY DEMOGRAPHIC SEGMENTATION, 2024 TO 2035 (USD Billion)
139. 6.139 HEALTHCARE, BY SERVICE DELIVERY MODEL, 2024 (% SHARE)
140. 6.140 HEALTHCARE, BY SERVICE DELIVERY MODEL, 2024 TO 2035 (USD Billion)
141. 6.141 HEALTHCARE, BY PROVIDER TYPE, 2024 (% SHARE)
142. 6.142 HEALTHCARE, BY PROVIDER TYPE, 2024 TO 2035 (USD Billion)
143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.2.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.2.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.2.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.3.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.3.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.3.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.3.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.4.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.4.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.4.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.4.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.5.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.5.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.5.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.5.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.6.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.6.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.6.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.6.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.7.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.7.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.7.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.7.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.8.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.8.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.8.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.8.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.9.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.9.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.9.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.9.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.10.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.10.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.10.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.10.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.11.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.11.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.11.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.11.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.12.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.12.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.12.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.12.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.13.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.13.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.13.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.13.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.14.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.14.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.14.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.14.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.15.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.15.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.15.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.15.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.16.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.16.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.16.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.16.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.17.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.17.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.17.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.17.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.18.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.18.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.18.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.18.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.19.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.19.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.19.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.19.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.20.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.20.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.20.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.20.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.21.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.21.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.21.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.21.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.22.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.22.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.22.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.22.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.23.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.23.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.23.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.23.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.24.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.24.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.24.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.24.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.25.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.25.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.25.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.25.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.26.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.26.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.26.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.26.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.27.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.27.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.27.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.27.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.28.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.28.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.28.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.28.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.29.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.29.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.29.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.29.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY TREATMENT TYPE, 2025-2035 (USD Billion)
  2. 7.30.2 BY DISORDER TYPE, 2025-2035 (USD Billion)
  3. 7.30.3 BY DEMOGRAPHIC SEGMENTATION, 2025-2035 (USD Billion)
  4. 7.30.4 BY SERVICE DELIVERY MODEL, 2025-2035 (USD Billion)
  5. 7.30.5 BY PROVIDER TYPE, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

behavioral-health-market Market Segmentation

behavioral-health-market By Treatment Type (USD Billion, 2025-2035)

Psychotherapy
Medication
Counseling
Support Groups
Teletherapy

behavioral-health-market By Disorder Type (USD Billion, 2025-2035)

Anxiety Disorders
Mood Disorders
Personality Disorders
Psychotic Disorders
Substance Use Disorders

behavioral-health-market By Demographic Segmentation (USD Billion, 2025-2035)

Age
Gender
Income Level
Education Level
Occupation

behavioral-health-market By Service Delivery Model (USD Billion, 2025-2035)

Inpatient Services
Outpatient Services
Residential Treatment
Community-Based Services
Telehealth Services

behavioral-health-market By Provider Type (USD Billion, 2025-2035)

Psychiatrists
Psychologists
Licensed Clinical Social Workers
Counselors
Nurse Practitioners

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”